Mezagitamab
CAS No. 2227490-52-8
Mezagitamab ( —— )
产品货号. M36811 CAS No. 2227490-52-8
Mezagitamab (TAK-079) 是一种 IgG1λ 抗 CD38 的单克隆抗体。Mezagitamab 通过抗体和补体依赖性细胞毒性耗尽表达 CD38 的肿瘤细胞。Mezagitamab 在复发/难治性多发性骨髓瘤 (RRMM) 和原发性血小板减少性紫癜 (ITP) 中有潜在应用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥5567 | 有现货 |
|
| 10MG | ¥7496 | 有现货 |
|
| 25MG | ¥10881 | 有现货 |
|
| 50MG | ¥14694 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Mezagitamab
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Mezagitamab (TAK-079) 是一种 IgG1λ 抗 CD38 的单克隆抗体。Mezagitamab 通过抗体和补体依赖性细胞毒性耗尽表达 CD38 的肿瘤细胞。Mezagitamab 在复发/难治性多发性骨髓瘤 (RRMM) 和原发性血小板减少性紫癜 (ITP) 中有潜在应用。
-
产品描述Mezagitamab (TAK-079) is a IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement dependent cytotoxicity. Mezagitamab has potential application in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP).
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体CD38
-
研究领域——
-
适应症——
化学信息
-
CAS Number2227490-52-8
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Laprafylline
Laprafylline is a xanthine compound with inhibitory effects on bronchoconstriction in vivo and antitumor activity.Laprafylline acts as a competitive serotonergic antagonist at low concentrations, and inhibits constriction induced by hist at high difficulties.
-
Cgp 29030A
CGP 29030A is a new piperazine derivative with analgesic activity and significant inhibitory effect on potentially nociceptive dorsal horn neurons, which can be used to study painful disorders.
-
(+)-beta-Cedrene
β-cedrene are bioactive sesquiterpenes found in cedar essential oil and exert antiseptic, anti-inflammatory, antispasmodic, tonic, astringent, diuretic, sedative, insecticidal, and antifungal activities.
021-51111890
购物车()
sales@molnova.cn

